Clinical Trial Update: MK0916 in Patients With Type 2 Diabetes and Metabolic Syndrome (0916-005) [Phase 2]

View source ↗

Summary

Phase 2 clinical trial update for MK0916 in adults with Type 2 diabetes mellitus and metabolic syndrome; the study has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Metabolic Syndrome
• Type 2 Diabetes Mellitus

Drugs mentioned

• MK0916

Snippet

Sponsor: Merck Sharp & Dohme LLC | Conditions: Diabetes Mellitus, Type 2, Metabolic Syndrome | Phase 2 | Status: COMPLETED